Edesa Biotech Inc (EDSA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $26.21M
Last updated: Nov 17, 2026 at 11:04 AM ET
Edesa Biotech Inc (EDSA) Competitors
The companies most similar to Edesa Biotech are Evaxion Biotech AS (EVAX), ImageneBio (IMA) and Estrella Immunopharma (ESLA). By market cap, Edesa Biotech ranks 7th of the 13 companies on this page; ImageneBio (IMA) is the largest at $43.22M.
Peer Comparison
EDSA's revenue growth of -99.9% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Edesa Biotech (EDSA) | $26.21M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| Evaxion Biotech AS (EVAX) | $25.27M | N/A | 0.2x | -115.5% | -79.5% | -100.0% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Lite Strategy, Inc. (LITS) | $25.30M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CervoMed Inc. (CRVO) | $25.57M | N/A | N/A | 0.0% | N/A | -99.6% | 0.00% |
| Dare Bioscience Inc (DARE) | $12.93M | N/A | 6.4x | 0.0% | N/A | 499.6% | 0.00% |
| Immutep Ltd ADR (IMMP) | $25.64M | N/A | 2.2x | 0.0% | N/A | 633.0% | 0.00% |
| Peer median | $26.14M | N/A | 4.3x | 0.0% | -79.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Edesa Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Evaxion Biotech AS (EVAX) | Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company... | EVAX competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Lite Strategy, Inc. (LITS) | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. | LITS competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| CervoMed Inc. (CRVO) | CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. | CRVO competitors |
| Dare Bioscience Inc (DARE) | Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. | DARE competitors |
| Immutep Ltd ADR (IMMP) | Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. |
Frequently Asked Questions About EDSA
Who are Edesa Biotech's main competitors?
The companies most similar to Edesa Biotech include Evaxion Biotech AS (EVAX), ImageneBio (IMA), Estrella Immunopharma (ESLA), INmune Bio (INMB) and Lite Strategy (LITS), listed from the closest match.
Who is Edesa Biotech's biggest competitor?
ImageneBio (IMA) is the largest of the similar companies at $43.22M; Evaxion Biotech AS (EVAX) is the closest match by business profile, size, sector and industry.
How does EDSA stock compare with its competitors?
EDSA's net margin is 0.0% against a peer median of 0.0%.
Which of Edesa Biotech's competitors pays a higher dividend?
Edesa Biotech pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Edesa Biotech bigger than its competitors?
No. Edesa Biotech is 7th by market cap among the 13 companies on this page; the largest is ImageneBio (IMA) at $43.22M.
EDSA pages: Overview, Earnings, Financials, Competitors